|

Trauma-Focused Cognitive Behavioral Therapy in Unaccompanied Refugee Minors With PTSD in Greece: An RCT

RECRUITINGN/ASponsored by Theodora Anastasiou
Actively Recruiting
PhaseN/A
SponsorTheodora Anastasiou
Started2023-04-13
Est. completion2025-12
Eligibility
Age15 Years – 18 Years
Healthy vol.Accepted

Summary

This single-blinded, multicentered, randomized controlled trial aims to evaluate the effectiveness of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) compared to Treatment-as-Usual (TAU) in reducing post-traumatic stress symptoms among unaccompanied refugee minors (UAMs) residing in accommodation centers and Supported Independent Living (SIL) programs in Greece. Participants aged 15-18 will be randomly assigned to either a TF-CBT intervention group or a TAU control group. The intervention will be delivered by trained psychologists under supervision and culturally adapted to the Greek refugee context. Assessments will occur at baseline, post-intervention, and three months later, using standardized psychometric tools. Secondary outcomes include changes in comorbid psychiatric symptoms (depression, anxiety, somatic symptoms), emotional and behavioral difficulties, and quality of life. The study also investigates potential moderators of treatment response such as age, gender, trauma history, and psychiatric comorbidity.

Eligibility

Age: 15 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Be unaccompanied upon arrival in Greece and aged between 15-18 years old.
* Being diagnosed with PTSD based on DSM-5 criteria. Young refugees with post-traumatic stress symptoms (PTSS), as delineated by high or moderate trauma-related distress in the Child and Adolescent Trauma Screen (CATS), will also be eligible to participate in the study.
* Reside in an accommodation center or SIL program for UAMs in Greece.
* Have a stable living arrangement for at least 2-3 weeks prior to the intervention.
* Not be expected to relocate within the 2-3 months following the start of the intervention.

Exclusion Criteria:

* a diagnosed intellectual disability (IQ \< 70) or another developmental disorder
* acute suicidality or life-threatening self-harm behavior
* significant risk of harm to others
* comorbidity with bipolar disorder or a psychotic disorder
* substance abuse.

Conditions7

AnxietyAnxiety SymptomsDepressionDepressive SymptomsEmotional and Behavioral DifficultiesPost Traumatic Stress Disorder (PTSD)Somatic Symptoms

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.